News Published: April 8, 2021

VERIGRAFT was selected as a finalist in the 2021 Lyfebulb-CSL Behring Innovation Challenge

Lyfebulb Challenge

Latest news

See all news
Published: December 3, 2025

First-in-Human Results for VERIGRAFT’s Individualized Tissue-Engineered Vein (P-TEV) in Severe CVI
Published: November 3, 2025

VERIGRAFT Q3 2025 – From Validation to Readiness for the Next Phase
Published: October 29, 2025

P-TEV Clinical Trial Results: VERIGRAFT Completes Phase I/II
Published: August 7, 2025

Q2 2025: Clinical Progress and Strategic Development
News Published: May 27, 2025

Regulatory Greenlight Achieved in our Clinical Trial
News Published: April 30, 2025

VERIGRAFT winner of the Business Sweden’s Catalyst Program 2025